BioReliance announces the introduction of its new protein array platform that offers greater sensitivity, reduced testing time and reliable results. The platform, brand-named ReliArray™, can simultaneously screen for four...
Tuesday November 11, 8:00 am ET The Carton of Caring® Donation Program helps children experience the joy of giving ROCKVILLE, Md., Nov. 11 /PRNewswire/ -- This first-of-its kind partnership between toy-maker, Learning Curve...
Phase 2 Randomized Study Under Consideration ROCKVILLE, Md., November 10, 2008 /PRNewswire-FirstCall/ -- EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and...
Monday November 10, 8:00 am ET ROCKVILLE, Md., Nov. 10 /PRNewswire-FirstCall/ -- News ) today announced financial results for the third quarter ended September 30, 2008. For the nine months ended September 30, 2008, the Company...
School to Use Software-as-a-Service CRM Solution to Enhance Undergraduate Recruitment Efforts and Manage Enrollment Growth ROCKVILLE, MD--(Marketwire - November 10, 2008) - Intelliworks, Inc., a leading provider of relationship...
Nov 10, 2008 (Nuclear Regulatory Commission Documents and Publications/ContentWorks via COMTEX) -- SUMMARY: The NRC is soliciting public comment on its draft report titled "Tsunami Hazard Assessment at Nuclear Power Plant Sites...
Nov 10, 2008 (Nuclear Regulatory Commission Documents and Publications/ContentWorks via COMTEX) -- FOR FURTHER INFORMATION CONTACT: Mark Orr, Regulatory Guide Development Branch, Division of Engineering, Office of Nuclear...
BALTIMORE (AP) - The Maryland attorney general's office says a Rockville-based home builder has agreed to pay back customers whose contracts it canceled. The attorney general's office said Friday it had reached a settlement...
November 5, 2008 (ROCKVILLE, MD) – Bethesda Softworks®, a ZeniMax Media company, announced that its hit title, Fallout® 3 has enjoyed record sales at launch, reflecting the huge consumer demand for the game.
ROCKVILLE, Md., Nov. 7 /PRNewswire-FirstCall/ -- EntreMed, Inc. a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that James S. Burns,...